A phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3.

Park YC, Ouh YT, Sung MH, Park HG, Kim TJ, Cho CH, Park JS, Lee JK

Open source

DOI
10.3802/jgo.2019.30.e88
Published
2019 Nov
Container
Journal of gynecologic oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3802/jgo.2019.30.e88,
  title = {A phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3.},
  author = {Park YC and Ouh YT and Sung MH and Park HG and Kim TJ and Cho CH and Park JS and Lee JK},
  year = {2019},
  journal = {Journal of gynecologic oncology},
  doi = {10.3802/jgo.2019.30.e88},
  url = {https://doi.org/10.3802/jgo.2019.30.e88}
}

RIS

TY  - JOUR
TI  - A phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3.
AU  - Park YC
AU  - Ouh YT
AU  - Sung MH
AU  - Park HG
AU  - Kim TJ
AU  - Cho CH
AU  - Park JS
AU  - Lee JK
PY  - 2019
JO  - Journal of gynecologic oncology
DO  - 10.3802/jgo.2019.30.e88
UR  - https://doi.org/10.3802/jgo.2019.30.e88
ER  - 

APA

YC, P., YT, O., MH, S., HG, P., TJ, K., CH, C., JS, P., & JK, L. (2019). A phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3.. Journal of gynecologic oncology. https://doi.org/10.3802/jgo.2019.30.e88

Source records